Coronary microvascular dysfunction (CMD) is a key pathophysiological feature of hypertrophic cardiomyopathy (HCM), contributing to myocardial ischemia and representing a critical determinant of patients' adverse outcome. The molecular mechanisms underlying the morphological and functional changes of CMD are still unknown. Aim of this study was to obtain insights on the molecular pathways associated with microvessel remodeling in HCM.
RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy / Pisano, Annalinda; Pera, Loredana Le; Carletti, Raffaella; Cerbelli, Bruna; Pignataro, Maria G; Pernazza, Angelina; Ferre, Fabrizio; Lombardi, Maria; Lazzeroni, Davide; Olivotto, Iacopo; Rimoldi, Ornella E; Foglieni, Chiara; Camici, Paolo G; D'Amati, Giulia. - In: MICROCIRCULATION. - ISSN 1073-9688. - (2022). [10.1111/micc.12790]
RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy
Pisano, AnnalindaCo-primo
;Pera, Loredana LeCo-primo
;Carletti, Raffaella;Cerbelli, Bruna;Pignataro, Maria G;Pernazza, Angelina;Ferre, Fabrizio;d'Amati, Giulia
Ultimo
2022
Abstract
Coronary microvascular dysfunction (CMD) is a key pathophysiological feature of hypertrophic cardiomyopathy (HCM), contributing to myocardial ischemia and representing a critical determinant of patients' adverse outcome. The molecular mechanisms underlying the morphological and functional changes of CMD are still unknown. Aim of this study was to obtain insights on the molecular pathways associated with microvessel remodeling in HCM.| File | Dimensione | Formato | |
|---|---|---|---|
|
Pisano_RNA‐seq-profiling_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
2.27 MB
Formato
Adobe PDF
|
2.27 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
